AbbVie's Rinvoq shows superiority over Humira in head-to-head arthritis study

Health

AbbVie’s Rinvoq shows superiority over Humira in head-to-head arthritis study

Mon, Oct 20, 2025 0 Comments

Audio By Carbonatix

(Reuters) -AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company’s previous bestseller Humira, meeting the main goal of a head-to-head trial.

(Reporting by Puyaan Singh in Bengaluru)

Previous Exclusive-Kabul must rein in militants for ceasefire to hold, says Pakistan

Next Chinese battery maker CATL posts faster profit growth in third quarter

Salem News Channel | Today

More Health Headlines

Spire Healthcare agrees £1.03 billion takeover by Toscafund and others
US phases out $45M annual support for Namibia HIV program
Endometriosis can elude diagnosis for years. What to know about the disease and new ways to find it
Chimpanzees once used for vaccine research get health checks as part of long-term care
US embassy issues health alert for Cuba amid oil blockade, sanctions

Other News to Consider

Robin Morgan, poet and feminist whose allies included Jane Fonda and Gloria Steinem, dies at 85
Vietnam, Myanmar agree to deepen defence ties during Min Aung Hlaing visit
MLB roundup: Guardians earn two walk-off wins in DH sweep of Tigers
The Media Line: Netanyahu Declares Fall of Iranian Regime Is ‘‘Within Reach’
Turning Point is laying the groundwork to shape Republican presidential primary in 2028

Follow SRNNews.com

on Facebook

@SRNNews

Subscribe to our Newsletters RSS Feeds

X CLOSE

Email to a Friend

AbbVie’s Rinvoq shows superiority over Humira in head-to-head arthritis study

(Reuters) -AbbVie said on Monday its newer arthritis drug Rinvoq showed superiority over the company’s previous bestseller Humira, meeting the main goal of a head-to-head trial. (Reporting by Puyaan Singh in Bengaluru)

X close